- Controlling the drug-resistant tuberculosis epidemic in India: challenges and implications
-
Husain AA, Kupz A, Kashyap RS
- KMID: 2516495
- Epidemiol Health.
- 2021;43(1):e2021022.
- doi: 10.4178/epih.e2021022
India has a higher tuberculosis (TB) burden than any other country, accounting for an estimated one-fourth of the global burden. Drug-resistant tuberculosis (DR-TB) presents a major public health problem in... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative evaluation of booster efficacies of BCG, Ag85B, and Ag85B peptides based vaccines to boost BCG induced immunity in BALB/c mice: a pilot study
-
Husain AA, Warke SR, Kalorey DR, Daginawala HF, Taori GM, Kashyap RS
- KMID: 2049111
- Clin Exp Vaccine Res.
- 2015 Jan;4(1):83-87.
- doi: 10.7774/cevr.2015.4.1.83
PURPOSE: In the present study booster efficacies of Ag85 B, Bacillus Calmette-Guerin (BCG), and Ag85B peptides were evaluated using prime boost regimes in BALB/c mice. MATERIALS AND METHODS: Mice were primed... -
- CITED
-
- Close
- SHARE
-
- Close
- Assessment of immunological markers and booster effects of Ag85B peptides, Ag85B, and BCG in blood of BCG vaccinated children: a preliminary report
-
Husain AA, Daginawla , Singh L, Kashyap RS
- KMID: 2152695
- Clin Exp Vaccine Res.
- 2016 Jan;5(1):31-40.
- doi: 10.7774/cevr.2016.5.1.31
PURPOSE: In the present study, the protective immunological markers in serum and peripheral blood mononuclear cells (PBMCs) of bacillus Calmette-Guerin (BCG) vaccinated and unvaccinated children were evaluated after vaccination. Further,... -
- CITED
-
- Close
- SHARE
-
- Close
- Investigation of Immune Biomarkers Using Subcutaneous Model of M. tuberculosis Infection in BALB/c Mice: A Preliminary Report
-
Husain AA, Daginawala HF, Warke SR, Kalorey DR, Kurkure NV, Purohit HJ, Taori GM, Kashyap RS
- KMID: 2168033
- Immune Netw.
- 2015 Apr;15(2):83-90.
- doi: 10.4110/in.2015.15.2.83
Evaluation and screening of vaccines against tuberculosis depends on development of proper cost effective disease models along with identification of different immune markers that can be used as surrogate endpoints... -
- CITED
-
- Close
- SHARE
-
- Close
